Neuroscience
18 Methoxycoronaridine
87%
Status Epilepticus
85%
Electroencephalography
59%
Ictal
58%
Eicosanoid Receptor
57%
Encephalitis
57%
Electroencephalography
55%
Aspartic Acid
51%
Cognitive Disorders
48%
Behavior (Neuroscience)
34%
Interpeduncular Nucleus
34%
Antiseizure Medication
31%
Receptor Antibody
30%
Acetylcholine Release
29%
Amnesia
27%
Morphine
23%
Acetylcholine
23%
Epileptic Absence
22%
Temporal Lobe Epilepsy
21%
Epileptic Seizure
20%
Anticonvulsant
20%
Intractable Epilepsy
19%
Nicotinic Receptor
18%
Asystole
17%
Seizure Types
17%
Brain Imaging
17%
Neurogenesis
17%
Corpus Callosotomy
17%
Morphine Withdrawal
17%
Hyporeflexia
17%
Dextro Aspartic Acid
17%
Taste Aversion
17%
Video-Electroencephalogram
17%
Magnetoencephalography
17%
Monoclonal Antibody
17%
Ghrelin
17%
Methyldienolone
17%
Tacrine
17%
Galantamine
17%
Coma
17%
Rostral Ventromedial Medulla
17%
Hemispherectomy
17%
Alzheimer's Disease
17%
Anakinra
17%
Cholinergic
14%
Working Memory
14%
Mesolimbic Pathway
13%
Event-Related Potential
11%
Cognitive Process
11%
Anti-Seizure Medication
11%
Keyphrases
New-onset Refractory Status Epilepticus (NORSE)
51%
Febrile Infection-related Epilepsy Syndrome (FIRES)
38%
18-Methoxycoronaridine
34%
Anti-N-methyl-D-aspartate Receptor Encephalitis
34%
Anti-N-methyl-D-aspartate Receptor Antibody
23%
Seizure
19%
Cognitive Impairment
19%
Anti-obesity
19%
Spatiotemporal Propagation
17%
Corpus Callosotomy
17%
Immune Checkpoint Inhibitor Therapy
17%
EEG Findings
17%
EEG Seizure
17%
Dual Disorders
17%
Anterior Corpus Callosotomy
17%
Seizure Burden
17%
Invasive EEG
17%
International Consensus
17%
Single-center Experience
17%
Critical Care EEG
17%
Chatter
17%
Morphine Withdrawal Signs
17%
Tick Paralysis
17%
Conditioned Taste Aversion
17%
Psychogenic Nonepileptic Spells
17%
Dopamine Overflow
17%
Biospecimens
17%
Galanthamine
17%
Lateral Medullary Infarction
17%
Aberrant Neurogenesis
17%
Medial Habenula
17%
Habenula nucleus
17%
Hypoglycemic Coma
17%
Ictal Asystole
17%
Standard Operating Procedures
17%
Seizure Clusters
17%
EEG Interpretation
17%
Encephalopathy
17%
Improgan
17%
Hemispherectomy
17%
Child Neurology
17%
Myeloid Differentiation Factor 88 (MyD88)
17%
Consensus Recommendations
17%
Psychosocial Outcomes
17%
Needle Trajectory
17%
Adult Patients
14%
Sucrose Intake
10%
Immune Checkpoint Inhibitors
9%
Central Nervous System Malignancies
9%
Pediatric Patients
9%
Medicine and Dentistry
Epileptic Seizure
100%
Status Epilepticus
85%
Ictal
40%
Infection
37%
Epilepsy Syndromes
37%
Drug Therapy
25%
Electroencephalogram
23%
Anticonvulsant
20%
Systematic Review
19%
Brain Imaging
19%
Brain Disease
17%
Heart Arrest
17%
Corpus Callosotomy
17%
Telemedicine
17%
18 Methoxycoronaridine
17%
Quality Improvement
17%
Injury
17%
Tick Paralysis
17%
Faintness
17%
COVID-19
17%
Biological Marker
17%
Intensive Care
17%
Hypoglycemic Coma
17%
Anti N Methyl D Aspartate Receptor Encephalitis
17%
Immune Checkpoint Inhibitor
17%
Ambulatory Care
17%
Clinical Handover
17%
Symptom
15%
Disease
13%
Pediatrics Patient
13%
Central Nervous System
12%
Observational Study
10%
Patient Referral
10%
Cancer
9%
Diagnosis
9%
Patient-Data
8%
Patient Safety
8%
DNA Template
8%
Medical Error
8%
Cognitive Defect
5%
Health Care Cost
5%
